Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (40)
  • 2024 (40)
  • 2023 (78)
  • 2022 (55)
  • 2021 (33)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (242)
  • Terrorism (14)

Drug Name

  • Opioids (42)
  • Oxycodone (37)
  • Fentanyl (30)
  • Hydromorphone (13)
  • Synthetic Opioids (10)
  • Cocaine (8)
  • Methamphetamine (8)
  • Benzodiazepines (7)
  • Morphine (6)
  • Heroin (4)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • Marijuana (Cannabis) (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (35)
  • New England (33)
  • New York (29)
  • Seattle (22)
  • Chicago (18)
  • Houston (16)
  • New Jersey (15)
  • Atlanta (13)
  • Headquarters (10)
  • Miami (9)
  • New Orleans (8)
  • San Francisco (8)
  • St. Louis (7)
  • El Paso (6)
  • Dallas (5)
  • Rocky Mountain (5)
  • Los Angeles (4)
  • Phoenix (4)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
Clear All Results
PRESS RELEASE

Dedham Veterinarian Agrees To Pay $15,000 Settlement To Resolve Allegations Of Inadequate Recordkeeping Of Controlled Substances

September 21, 2022
BOSTON – A Dedham veterinarian has agreed to resolve allegations that he maintained inadequate records of controlled substances, improperly stored controlled substances at his office and residence, ordered controlled substances without a Drug Enforcement Administration (DEA) registration, and failed to report he was on probation on his DEA registration forms...
September 21, 2022
PRESS RELEASE

Former Dentist Charged Federally with Illegally Distributing Prescription Opiates

September 13, 2022
SEATTLE – A former dentist who practiced in Renton until his license was indefinitely suspended by the Washington State Dental Commission, was indicted federally for four counts of distributing a controlled substance, announced U.S. Attorney Nick Brown. Luke Edward St. Marie, 34, appeared in federal court today and entered pleas...
September 13, 2022
PRESS RELEASE

Woodstock Dentist Sentenced to Probation and Pays $100,000 Civil Penalty for Fraudulently Acquiring Oxycodone

August 25, 2022
ALBANY, NEW YORK – Vivian Letizia, age 64, of Woodstock, New York, was sentenced today to one year of probation for acquiring and obtaining a controlled substance by misrepresentation, fraud, deception or subterfuge. Letizia was also ordered to undergo drug treatment and pay a $5,000 fine. Letizia has also paid...
August 25, 2022
PRESS RELEASE

Nurse Arrested for Diversion of Controlled Substances

August 11, 2022
BRADFORD, Vt. - Amy J. Vickers, 44, of Bradford, Vermont was arrested today on a complaint charging her with obtaining controlled substances by misrepresentation, fraud, forgery, deception or subterfuge, U.S. Attorney Jane E. Young announced. According to the complaint, on June 17, 2022, Vickers was working as a nurse at...
August 11, 2022
PRESS RELEASE

New Jersey Pharmacy Admits Illegal Distribution of Prescription Opioids and Kickback Scheme

August 03, 2022
NEWARK, N.J. – Susan A. Gibson, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Scott J. Lampert, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of Inspector General, Office of Investigations-New Jersey Field Office, Patrick J. Hegarty, Defense Criminal Investigative...
August 03, 2022
PRESS RELEASE

Former Nurse Sentenced to 18 Months in Federal Prison for Tampering with Morphine Medications at Moses Lake Clinic

August 01, 2022
SPOKANE, Wash. – Vanessa R. Waldref, the United States Attorney for the Eastern District of Washington, announced today that Esther Rae Tuller, age 41, of Moses Lake, Washington, was sentenced today in federal court in Spokane for tampering with morphine medication while working as a registered nurse. Chief United States...
August 01, 2022
PRESS RELEASE

Justice Department Obtains Temporary Restraining Order to Prevent Tampa-Area Physician from Writing Opioid Prescriptions

July 29, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area physician from prescribing opioids and other controlled substances, the Department of Justice announced today. In a complaint filed on July 18, and unsealed yesterday, the United States alleges that Dr. Neelam Taneja Uppal unlawfully wrote opioid prescriptions...
July 29, 2022
PRESS RELEASE

Minnesota Pharmacist Pleads Guilty to Misappropriating and Adulterating Prescription Pain Medication

July 20, 2022
MINNEAPOLIS – A Minneapolis woman has pleaded guilty to misappropriating and adulterating prescription morphine while working as a pharmacist. According to court documents, on October 30, 2019, Jennifer Lee Draheim, 42, a pharmacist at Coburn’s Pharmacy in Ramsey, removed a bottle of morphine sulfate from the Scheduled Drug Cabinet and...
July 20, 2022
PRESS RELEASE

Oklahoma City Hospital Pays $120,000 to Settle Civil Penalty Claims

July 19, 2022
OKLAHOMA CITY, OK – INTEGRIS ProHealth, Inc., and its parent, INTEGRIS Health, Inc. (collectively, “INTEGRIS”) paid $120,000 to settle civil penalty claims stemming from allegations that Integris Baptist Medical Center Pharmacy (“Integris Pharmacy”), which is owned and operated by INTEGRIS ProHealth, Inc., violated the Comprehensive Drug Abuse Prevention and Control...
July 19, 2022
PRESS RELEASE

New Mexico Pharmacy Agrees to Settlement Relating to Violations of the Controlled Substances Act

July 12, 2022
ALBUQUERQUE, N.M. – Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Joe’s Pharmacy of Peralta, New Mexico, has agreed to pay to the United States $50,000 representing civil penalties under the Controlled Substances Act (CSA). The agreement settles civil claims against Joe’s Pharmacy...
July 12, 2022
Showing 171 - 180 of 256 results

Pagination

  • First page «
  • Previous page ‹
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Current page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster